Clinical trial
A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder
NCT00232414 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder
- Lead sponsor
- University of Cincinnati
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2005
- Completion date
- December 31, 2007
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bipolar i disorder